David M Markovitz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David M Markovitz

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2017

High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor TherapyNirit Mor-Vaknin, Miguel Rivas, Maureen Legendre, et al.

Cell|October 27, 2015

Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activityMichael D Swanson, Daniel M Boudreaux, Loïc Salmon, et al.

Cell Reports. Medicine|October 4, 2022

A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivoJasper Fuk-Woo Chan, Yoo Jin Oh, Shuofeng Yuan, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2017

Cell|October 27, 2015

Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activityMichael D Swanson, Daniel M Boudreaux, Loïc Salmon, et al.

Cell Reports. Medicine|October 4, 2022

A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivoJasper Fuk-Woo Chan, Yoo Jin Oh, Shuofeng Yuan, et al.

Pageof 8